RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-84
Malaria parasiteP. berghei
Genotype
Genetic modification not successful
DisruptedGene model (rodent): PBANKA_1222500; Gene model (P.falciparum): PF3D7_0808200; Gene product: plasmepsin X (plasmepsin X; aspartyl protease)
PhenotypeNo phenotype has been described
Last modified: 18 February 2009, 01:03
  *RMgm-84
Successful modificationThe gene/parasite could not be changed/generated by the genetic modification.
The following genetic modifications were attempted Gene disruption
Number of attempts to introduce the genetic modification 3
Reference (PubMed-PMID number) Reference 1 (PMID number) : 18761621
top of page
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA 2.34
Other information parent lineP. berghei ANKA 2.34 is a cloned, gametocyte producer line of the ANKA strain (PubMed: PMID: 15137943).
top of page
Attempts to generate the mutant parasite were performed by
Name PI/ResearcherA. Ecker; R.E. Sinden
Name Group/DepartmentDivision of Cell and Molecular Biology
Name InstituteImperial College
CityLondon
CountryUnited Kingdom
  Disrupted: Mutant parasite with a disrupted gene
top of page
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1222500
Gene Model P. falciparum ortholog PF3D7_0808200
Gene productplasmepsin X
Gene product: Alternative nameplasmepsin X; aspartyl protease
top of page
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct usedPlasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitetgdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationC-terminal c-myc tagging of the gene was successful, confirming that these gene loci can be targeted.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1GGGGTACCTTGTCTGTTATACATATACCCTC
Additional information primer 1AE14a (KpnI); 5'
Sequence Primer 2TTGGGCCCTCAGTTTTTATTAACGTTGTTAC
Additional information primer 2AE14b (endogenous HindIII site); 5'
Sequence Primer 3ATGGGAGAGGAATTCATAAATAG
Additional information primer 3AE14c (EcoRI); 3'
Sequence Primer 4GGGGATCCAGTTTTAAATTGCATACGAAAAC
Additional information primer 4AE14d (BamHI); 3'
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6
top of page
Conceptual design of the database: Dr. C.J. Janse (Leiden Malaria Research Group, Leiden, The Netherlands).
Technical design and realization: StudioDrie StudioDrie; S. Mededovic and A. van Wigcheren